Skip to main content

Table 4 Plasma levels of cytokines and growth factors before and during 3 months of treatment.

From: Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin

Cytokine or Chemokine

Day*

No. of Patients

Mean Concentration (pg/mL)

Change from Day -8 (pg/mL)

P value

IL-1α

-8

13

43

  
 

-4

12

47

5.2

0.224

 

1

13

48

4.8

0.172

 

9

13

48

4.6

0.437

 

3M

11

29

-16.3

0.033

IL-1β

-8

13

109

  
 

-4

12

115

8.0

0.295

 

1

13

122

13.6

0.052

 

9

13

125

16.4

0.069

 

3M

11

106

- 6.4

0.501

IL-6

-8

13

62

  
 

-4

12

76

12.3

0.166

 

1

13

72

10.2

0.164

 

9

13

79

16.3

0.094

 

3M

11

50

-18.4

0.014

IL-8

-8

13

12

  
 

-4

12

15

3.0

0.074

 

1

13

14

1.9

0.222

 

9

13

13

1.2

0.463

 

3M

11

8

- 4.6

0.019

IL-10

-8

13

9

  
 

-4

12

14

4.1

0.130

 

1

13

11

1.7

0.149

 

9

13

12

3.4

0.157

 

3M

11

9

- 1.2

0.418

TNF-α

-8

13

150

  
 

-4

12

177

26.8

0.265

 

1

13

174

23.4

0.200

 

9

13

152

1.6

0.937

 

3M

11

121

-39.8

0.377

GM-CSF

-8

13

2.9

  
 

-4

11

7.1

4.1

0.007

 

1

13

3.5

0.6

0.012

 

9

13

11.6

8.6

0.005

 

3M

11

5.7

2.6

0.041

M-CSF

-8

13

519

  
 

-4

12

505

-26.0

0.847

 

1

13

610

90.8

0.153

 

9

13

863

343.9

0.007

 

3M

11

558

13.6

0.902

  1. *Days -8, -4, 1, and 9 of the first chemoimmunotherapy course; 3M, 3 months after the first chemoimmunotherapy course was begun.
  2. P values not adjusted for multiple comparisons.